Kohei Kume, Ph.D. (Markus Müschen Lab) of Yale University, visited Morioka Lab .
Nishizuka gave a talk “Clinical implementation — somatic mutation as a tumor marker”at 2nd TOLIC Healthtech Device Forum/Healthtech Device Show.
Abe wins Excellent Award in the Student Research Contest at 2nd TOLIC Healthtech Device Forum/Healthtech Device Show for “Relapse prediction of bladder cancer using diigital PCR mutation monitoring from urine pellet DNA”.
Nishizuka Lab was introduced in Iwate Medical University doctor’s association periodicals (No. 135).
Nishizuka gave a talk “A new monitoring clinical examination for cancer relapse using circulating tumor DNA” as a luncheon seminar sponsored by LSI Medience/Finggal Link at 77th The General Meeting of the Japanese Society of Gastrointestinal Surgery (Yokohama).
Nishizuka gave a talk “Somatic mutations as tumor marker” as a luncheon seminar sponsored by MSD at 94th Semi-Annual Meeting of the Japanese Society of Pathology Tohoku Niigata (Morioka, Japan).
Nishizuka gave a talk about how digital PCR will enable our research to Thermo Fisher Scientific Genetic Science Group employees in Asia Pacific Japan region.
Our recent research was presented at Gantokai (annual meeting for surgeons).